ALLMedicine™ Vulvar Cancer Center

Feb 23rd, 2021 - To investigate the impact of a preoperative CT on surgical decision making in primary vulvar squamous cell carcinoma (VSCC) and the accuracy of detecting inguinal lymph node metastases (LNM). Secondly to assess prevalence and consequences of incid...

Feb 23rd, 2021 - This retrospective study aimed to assess the diagnostic performance of preoperative [18F]FDG-PET/CT in predicting the groin and pelvic lymph node (LN) status in a large single-centre series of vulvar cancer patients. Between January 2013 and Octob...

Feb 8th, 2021 - Sentinel lymph node biopsy (SLN) helps define lymph node status, a major prognostic factor in vulvar cancer. The aim of the current systematic review was to assess the use of indocyanine green (ICG) coupled with near-infrared (NIR) fluorescence im...

Jan 27th, 2021 - The optimal overall treatment time (OTT) from radical surgery to the end of adjuvant radiation therapy for some squamous cell carcinomas has been found to impact treatment outcomes. This study aims to identify the impact of OTT on overall survival...

Jan 20th, 2021 - Hospital volume-outcome relationship in vulvar cancer treatment: a Japanese Gynecologic Oncology Group study.|2021|Matsuo K,Nishio S,Matsuzaki S,Machida H,Mikami M,|

Nov 21st, 2017 - Vulvar cancer and vaginal cancer are relatively rare tumors, and there had been no established treatment principles or guidelines to treat these rare tumors in Japan. The first version of the Japan Society of Gynecologic Oncology (JSGO) guidelines...

Apr 25th, 2017 - The aim of this study was to develop clinically relevant and evidence-based guidelines as part of European Society of Gynaecological Oncology's mission to improve the quality of care for women with gynecologic cancers across Europe. The European S...

Jan 3rd, 2017 - Vulvar cancer is a rare gynecologic malignancy. Ninety percent of vulvar cancers are predominantly squamous cell carcinomas (SCCs), which can arise through human papilloma virus (HPV)-dependent and HPV-independent pathways. The NCCN Vulvar Cancer ...

Dec 31st, 2016 - Vulvar cancer is a rare gynecologic malignancy. Ninety percent of vulvar cancers are predominantly squamous cell carcinomas (SCCs), which can arise through human papilloma virus (HPV)–dependent and HPV-independent pathways.

May 26th, 2016 - For the first time, NCCN Guidelines are available for vulvar cancer, a rare gynecologic cancer. Early-stage cancers can be managed by surgery and observation, and many of these patients can be cured. Lymph node status drives treatment and correlat...

Feb 23rd, 2021 - To investigate the impact of a preoperative CT on surgical decision making in primary vulvar squamous cell carcinoma (VSCC) and the accuracy of detecting inguinal lymph node metastases (LNM). Secondly to assess prevalence and consequences of incid...

Feb 23rd, 2021 - This retrospective study aimed to assess the diagnostic performance of preoperative [18F]FDG-PET/CT in predicting the groin and pelvic lymph node (LN) status in a large single-centre series of vulvar cancer patients. Between January 2013 and Octob...

Feb 8th, 2021 - Sentinel lymph node biopsy (SLN) helps define lymph node status, a major prognostic factor in vulvar cancer. The aim of the current systematic review was to assess the use of indocyanine green (ICG) coupled with near-infrared (NIR) fluorescence im...

Jan 27th, 2021 - The optimal overall treatment time (OTT) from radical surgery to the end of adjuvant radiation therapy for some squamous cell carcinomas has been found to impact treatment outcomes. This study aims to identify the impact of OTT on overall survival...

Jan 20th, 2021 - Hospital volume-outcome relationship in vulvar cancer treatment: a Japanese Gynecologic Oncology Group study.|2021|Matsuo K,Nishio S,Matsuzaki S,Machida H,Mikami M,|

Mar 24th, 2020 - Lower genital tract cancers Dr. Emma C.

Apr 27th, 2018 - NEW ORLEANS – Leg lymphedema occurred in 19%-40% of women with a gynecologic cancer who underwent surgery with lymphadenectomy in a prospective study of 821 U. S.

Sep 1st, 2017 - “THE PELVIC EXAM REVISITED” ERIN HIGGINS, MD, AND CHERYL B. IGLESIA, MD (AUGUST 2017) Pelvic examination is essential to clinical care I have contemplated the issue of the routine screening pelvic exam now for several years.

Mar 30th, 2017 - NATIONAL HARBOR, MD – Cancer of the vulva is becoming more common, and as incidence is rising, so are death rates from the relatively rare malignancy. A new examination of women with early-stage vulvar cancer showed that recurrence was common, and.

Jun 19th, 2016 - SAN DIEGO – Fully half of gynecologic cancer survivors who are done with treatment and cancer free nonetheless report having moderate to severe symptoms 2 and even 5 years after diagnosis, Dr. Michelle Rowland reported at the annual meeting of the.